<DOC>
<DOCNO>EP-0635008</DOCNO> 
<TEXT>
<INVENTION-TITLE>
PIPERAZIDES OF SUBSTITUTED PHENYLALANINE DERIVATES AS THROMBIN INHIBITORS
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D21374	C07D31170	A61K31495	C07D29500	A61P702	C07D23904	C07D33324	A61K314402	C07D295185	C07D31100	C07D21300	A61K3144	A61K314402	A61K3144	C07D33300	A61P700	C07D29520	C07D29518	C07D23900	A61K31495	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	A61K	C07D	A61P	C07D	C07D	A61K	C07D	C07D	C07D	A61K	A61K	A61K	C07D	A61P	C07D	C07D	C07D	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D213	C07D311	A61K31	C07D295	A61P7	C07D239	C07D333	A61K31	C07D295	C07D311	C07D213	A61K31	A61K31	A61K31	C07D333	A61P7	C07D295	C07D295	C07D239	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
D,L-, L- and D-phenylalanine piperazides of formula (I) defined in the claim have been discovered which are clotting or thrombin and/or trypsin inhibitors. The compounds are easily absorbed orally, intraduodenally and especially rectally and are only slightly toxic.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
D,L-, L- or D-phenylalanine piperazides of formula



wherein R
1
 represents a basic group of formula


R
2
 represents phenyl, 4-methylphenyl, 2,4,6-trimethyl- or -triisopropylphenyl, 4-methoxy-2,3,6-trimethylphenyl,
2,2-dimethyl-6-methoxy- or 2,2,5,7,8-pentamethyl-chromanyl,

anthraquinonyl, 1- or 2-naphthyl, quinolyl or isoquinolyl or a camphor
residue, respectively; and

R
3
 represents an acyl residue of formula ―COX, wherein X means hydrogen,
alkyl C
1-3
 or cycloalkyl C
3-10
; or

   a benzyl residue wherein the aromatic residue may be substituted with a
halogen atom or an alkyl C
1-3
, alkoxy C
1-3
, hydroxy or nitro group; or

   a carboxamide residue of formula ―CONR
i
R
ii
, a thiocarboxamide residue of
formula -CSNR
i
R
ii
 or an ethylamide residue of formula ―CH
2
-CONR
i
R
ii
 in which R
i

= R
ii
 = H; R
i
 = R
ii
 = alkyl C
1-3
; R
i
 = H, R
ii
 = alkyl C
1-3
; R
i
 = H, R
ii
 = phenyl; or R
i
 and
R
ii
 together with the nitrogen atom form a 5- to 7-branched ring which may contain
a further hetero atom; or

   a residue of formula ―SO
2
-Y in which Y means alkyl C
1-3
, trifluoromethyl,
trichloromethyl, phenyl, 4-methylphenyl, 2,4,6-trimethyl- or ―triisopropylphenyl, 4-methoxy-2,3,6-trimethylphenyl,

2,2-dimethyl-6-methoxy- or 2,2,5,7,8-pentamethylchromanyl, 
anthraquinonyl, naphthyl, quinolyl or ―NR
iii
R
iv
,
respectively, in which R
iii
 and R
iv
 = H and/or are equal or unequal to alkyl C
1-3
; or

   a cycloaliphatic ring C
5-8
 which may be substituted with a hydroxyl or oxo
group; or

   a pyridyl, pyrimidinyl or N-methylpiperidyl residue; or

   a functionalized alkyl residue of formula ―(CH
2
)
n
-X' wherein the alkyl chain
is unbranched or branched, n = 1 to 8 and the functional residue X' represents

      a hydroxy group the H atom of which may be substituted with alkyl
C
1-3
, benzyl, phenyl, 4-methylphenyl, 2,4,6-trimethyl- or ―triisopropylphenyl,
4-methoxy-2,3,6-trimethylphenyl, anthraquinonyl, naphthyl, hydroxy alkyl

C
1-3
 or an acyl group of above formula ―COX, or

      a halogen atom, or

      a tertiary amino group of formula ―NR
v
R
vi
 wherein R
v
 and R
vi
 are
either same alkyl C
1-3
 groups or together with the nitrogen atom form a 5 to
7-branched ring to which one or two further rings may be added, or

      an acylaminomalonate group of formula


   wherein X has above denotation, a group of formula


   wherein X has above denotation, or a group of formula


and the salts thereof with mineral or organic acids.
Phenylalanine piperazides according to claim 1, wherein Y in the residue of
formula ―SO
2
-Y is methyl, trifluoromethyl or trichloromethyl.
Phenylalanine piperazides according to claim 1 or 2, wherein R
1
 represents
an amidino group of formula (a) and/or R
2
 means 2-naphthyl, anthraquinonyl,
2,4,6-triisopropylphenyl or 2,2,5,7,8-pentamethyl-chromanyl and/or R
3
 represents
an acyl residue of formula ―COX, a functionalized alkyl residue of formula ―(CH
2
)
n
-X',
a residue of formula ―SO
2
-Y, a carboxamide residue of formula ―CONR
i
R
ii
, 2-pyridyl
or 2-pyrimidinyl. 
Phenylalanine piperazides according to claim 3, wherein R
3
 means formyl,
acetyl or 2-hydroxyethyl.
Method for the synthesis of phenylalanine piperazides according to one of
claims 1 ― 4, wherein R
1
 represents an amidino group of formula (a), which
comprises converting a (D,L)-3-cyanophenylalanine alkylester of formula II



with a sulfochloride of formula R
2
-SO
2
Cl, wherein R
2
 has the denotation given in
claim 1, into a racemic compound of formula IV



from which the racemate of the sulfonylated cyanophenylalanine of formula V


is obtained by hydrolysis, or converting the compound of formula IV by enzymatic
ester hydrolysis with chymotrypsin into the L-configurated amino acid of formula V 

and converting the D-configurated amino alkyl carboxylates of formula IV obtained
by this procedure into the D-configurated amino carboxylic acids of formula V by

hydrolysis, converting the compound of formula V by coupling with a piperazine
derivative of formula VII



into the (D,L)-, D- or L-cyano compound with piperazide structure of formula VI


synthesizing the thioamide of formula VIII


by addition of H
2
S to the cyano residue, synthesizing a thioimidate halide of
formula IX


 
by conversion with an alkyl halide, or synthesizing an imidate halide of formula X



from the cyano compound with piperazide structure of formula VI, and converting
the compound of formula IX with ammonium acetate or the compound of formula X

in an alcoholic ammonia solution into a compound of formula XI


wherein X means halogen, preferentially chlorine.
Variant of the method according to claim 5 which, for the synthesis of (D,L)-,
D- or L-cyano compound with piperazide structure of formula VI obtained as an

intermediate, comprises protecting a (D,L), L- oder D-3-cyanophenylalanine by the
introduction of a BOC group at the amino function, converting the obtained

carboxylic acid of formula V, with the BOC group instead of the SO
2
-R
2
 group, with
a piperazine derivative of formula VII into the corresponding BOC-protected (D,L)-,

D- or L-cyano compound with piperazide structure of formula VI, with the BOC
group instead of the SO
2
-R
2
 group, and converting this compound after acidic 
separation of the BOC group and conversion with a sulfochloride of formula R
2
-SO
2
Cl
into the compound of formula VI.
Method for the synthesis of phenylalanine piperazides according to one of
claims 1 to 4, wherein R
1
 means aminomethyl of formula (b), which comprises
hydrogenating a cyano compound of formula VI as defined in claim 5.
Method according to claim 7 which comprises the catalytic hydrogenation of
the compound of formula VI.
Use of the phenylalanine piperazides according to one of claims 1 to 4 as
salts or free bases for the preparation of antithrombotically active drugs to be

administered subcutaneously or intravenously, in particular orally, rectally or
intraduodenally.
Antithrombotically active drug to be administered subcutaneously or
intravenously, in particular however by the oral, rectal or duodenal route, in which

an efficient quantity of at least one phenylalanine piperazide according to one of
claims 1 to 4 and appropriate additives are present.
Antithrombotically active drug according to claim 10, in the form of tablets,
dragées, capsules, pellets, suppositories, solutions, injections or transdermal

systems, such as plasters.
</CLAIMS>
</TEXT>
</DOC>
